| Dr Fadi N Bashour, MD | |
|
1299 Industrial Parkway North, Brunswick, OH 44212 | |
| (330) 225-6468 | |
| (330) 225-6534 |
| Full Name | Dr Fadi N Bashour |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 37 Years |
| Location | 1299 Industrial Parkway North, Brunswick, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821022708 | NPI | - | NPPES |
| 2551831 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 35 065615 (Ohio) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | 35065615 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medina Hospital | Medina, OH | Hospital |
| Southwest General Health Center | Middleburg heights, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Digestive Disease Consultants Of Medina, Llc | 2163523762 | 10 |
| North Coast Endoscopy, Llc | 7214194315 | 37 |
News Archive
Essential medications can be delivered as inhaled drugs to critically ill patients in the Intensive Care Unit (ICU) who require mechanical ventilation to breathe. Aerosol drug delivery is highly complex, however, and if not done properly the medication will not reach the lungs and therapy will be ineffective.
Power3 Medical Products, Inc. announced today that it has filed two provisional patent applications with the United States Patent and Trademark Office (USPTO) - one on Alzheimer's disease specific differential diagnosis in the clinical setting and the other on important differences in pathophysiology and therapeutic options for the genetically distinct groups of Alzheimer's disease patients.
Health Grades, Inc. (Nasdaq:HGRD) ("HealthGrades") today announced the extension of the offer period for the previously announced tender offer for all of the outstanding shares of common stock of HealthGrades for $8.20 per share in cash, without interest and less any applicable withholding taxes.
Halo Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel therapeutics for rare fibrotic diseases, announced today that the TREAT-NMD Advisory Committee on Therapeutics (TACT) has reviewed HT-100, Halo's drug candidate for Duchenne muscular dystrophy (DMD), and believes the compound has potential based on the proposed mechanism.
Clark McCarthy Healthcare Partners II, a joint venture of Clark Construction Group and McCarthy Building Companies Inc., was recently awarded a $648 million contract by The U.S. Army Corps of Engineers, Fort Worth District to build the Fort Bliss Replacement Hospital in El Paso.
› Verified 7 days ago
| Entity Name | Dayton Gastroenterology, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134345705 PECOS PAC ID: 9537064407 Enrollment ID: O20031204000041 |
News Archive
Essential medications can be delivered as inhaled drugs to critically ill patients in the Intensive Care Unit (ICU) who require mechanical ventilation to breathe. Aerosol drug delivery is highly complex, however, and if not done properly the medication will not reach the lungs and therapy will be ineffective.
Power3 Medical Products, Inc. announced today that it has filed two provisional patent applications with the United States Patent and Trademark Office (USPTO) - one on Alzheimer's disease specific differential diagnosis in the clinical setting and the other on important differences in pathophysiology and therapeutic options for the genetically distinct groups of Alzheimer's disease patients.
Health Grades, Inc. (Nasdaq:HGRD) ("HealthGrades") today announced the extension of the offer period for the previously announced tender offer for all of the outstanding shares of common stock of HealthGrades for $8.20 per share in cash, without interest and less any applicable withholding taxes.
Halo Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel therapeutics for rare fibrotic diseases, announced today that the TREAT-NMD Advisory Committee on Therapeutics (TACT) has reviewed HT-100, Halo's drug candidate for Duchenne muscular dystrophy (DMD), and believes the compound has potential based on the proposed mechanism.
Clark McCarthy Healthcare Partners II, a joint venture of Clark Construction Group and McCarthy Building Companies Inc., was recently awarded a $648 million contract by The U.S. Army Corps of Engineers, Fort Worth District to build the Fort Bliss Replacement Hospital in El Paso.
› Verified 7 days ago
| Entity Name | Digestive Disease Consultants Of Medina, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629284336 PECOS PAC ID: 2163523762 Enrollment ID: O20070726000584 |
News Archive
Essential medications can be delivered as inhaled drugs to critically ill patients in the Intensive Care Unit (ICU) who require mechanical ventilation to breathe. Aerosol drug delivery is highly complex, however, and if not done properly the medication will not reach the lungs and therapy will be ineffective.
Power3 Medical Products, Inc. announced today that it has filed two provisional patent applications with the United States Patent and Trademark Office (USPTO) - one on Alzheimer's disease specific differential diagnosis in the clinical setting and the other on important differences in pathophysiology and therapeutic options for the genetically distinct groups of Alzheimer's disease patients.
Health Grades, Inc. (Nasdaq:HGRD) ("HealthGrades") today announced the extension of the offer period for the previously announced tender offer for all of the outstanding shares of common stock of HealthGrades for $8.20 per share in cash, without interest and less any applicable withholding taxes.
Halo Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel therapeutics for rare fibrotic diseases, announced today that the TREAT-NMD Advisory Committee on Therapeutics (TACT) has reviewed HT-100, Halo's drug candidate for Duchenne muscular dystrophy (DMD), and believes the compound has potential based on the proposed mechanism.
Clark McCarthy Healthcare Partners II, a joint venture of Clark Construction Group and McCarthy Building Companies Inc., was recently awarded a $648 million contract by The U.S. Army Corps of Engineers, Fort Worth District to build the Fort Bliss Replacement Hospital in El Paso.
› Verified 7 days ago
| Entity Name | North Coast Endoscopy, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386378073 PECOS PAC ID: 7214194315 Enrollment ID: O20221213003298 |
News Archive
Essential medications can be delivered as inhaled drugs to critically ill patients in the Intensive Care Unit (ICU) who require mechanical ventilation to breathe. Aerosol drug delivery is highly complex, however, and if not done properly the medication will not reach the lungs and therapy will be ineffective.
Power3 Medical Products, Inc. announced today that it has filed two provisional patent applications with the United States Patent and Trademark Office (USPTO) - one on Alzheimer's disease specific differential diagnosis in the clinical setting and the other on important differences in pathophysiology and therapeutic options for the genetically distinct groups of Alzheimer's disease patients.
Health Grades, Inc. (Nasdaq:HGRD) ("HealthGrades") today announced the extension of the offer period for the previously announced tender offer for all of the outstanding shares of common stock of HealthGrades for $8.20 per share in cash, without interest and less any applicable withholding taxes.
Halo Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel therapeutics for rare fibrotic diseases, announced today that the TREAT-NMD Advisory Committee on Therapeutics (TACT) has reviewed HT-100, Halo's drug candidate for Duchenne muscular dystrophy (DMD), and believes the compound has potential based on the proposed mechanism.
Clark McCarthy Healthcare Partners II, a joint venture of Clark Construction Group and McCarthy Building Companies Inc., was recently awarded a $648 million contract by The U.S. Army Corps of Engineers, Fort Worth District to build the Fort Bliss Replacement Hospital in El Paso.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fadi N Bashour, MD 1299 Industrial Parkway North, Brunswick, OH 44212 Ph: (330) 225-6468 | Dr Fadi N Bashour, MD 1299 Industrial Parkway North, Brunswick, OH 44212 Ph: (330) 225-6468 |
News Archive
Essential medications can be delivered as inhaled drugs to critically ill patients in the Intensive Care Unit (ICU) who require mechanical ventilation to breathe. Aerosol drug delivery is highly complex, however, and if not done properly the medication will not reach the lungs and therapy will be ineffective.
Power3 Medical Products, Inc. announced today that it has filed two provisional patent applications with the United States Patent and Trademark Office (USPTO) - one on Alzheimer's disease specific differential diagnosis in the clinical setting and the other on important differences in pathophysiology and therapeutic options for the genetically distinct groups of Alzheimer's disease patients.
Health Grades, Inc. (Nasdaq:HGRD) ("HealthGrades") today announced the extension of the offer period for the previously announced tender offer for all of the outstanding shares of common stock of HealthGrades for $8.20 per share in cash, without interest and less any applicable withholding taxes.
Halo Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel therapeutics for rare fibrotic diseases, announced today that the TREAT-NMD Advisory Committee on Therapeutics (TACT) has reviewed HT-100, Halo's drug candidate for Duchenne muscular dystrophy (DMD), and believes the compound has potential based on the proposed mechanism.
Clark McCarthy Healthcare Partners II, a joint venture of Clark Construction Group and McCarthy Building Companies Inc., was recently awarded a $648 million contract by The U.S. Army Corps of Engineers, Fort Worth District to build the Fort Bliss Replacement Hospital in El Paso.
› Verified 7 days ago
Rammy Korkor, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4065 Center Rd, Brunswick, OH 44212 Phone: 330-558-0070 | |
Richard A. Del Rio, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1299 Industrial Parkway North, Brunswick, OH 44212 Phone: 330-225-6468 Fax: 330-225-6534 | |
An-jen Huang, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3724 Center Rd, Ste 102, Brunswick, OH 44212 Phone: 330-225-7733 Fax: 330-220-0902 | |
Su-chiao Kuo, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3724 Center Rd, Suite 102, Brunswick, OH 44212 Phone: 330-225-7733 Fax: 330-220-0902 | |
Maya Merheb, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1299 Industrial Pkwy N Ste 110, Brunswick, OH 44212 Phone: 330-225-6468 Fax: 330-225-6534 | |
Dr. David B Myers, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1299 Industrial Parkway North, Brunswick, OH 44212 Phone: 330-225-6468 Fax: 330-225-6534 | |
Marie Kuchynski, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4065 Center Rd Ste 210, Brunswick, OH 44212 Phone: 330-202-8411 Fax: 330-202-9315 |